[HTML][HTML] Outcomes in patients with sarcoidosis and COVID-19

O Nadeem, A Sharma, D Alaouie… - … Vasculitis, and Diffuse …, 2023 - ncbi.nlm.nih.gov
Methods: We included patients who had diagnoses of sarcoidosis and COVID-19 between
January 1, 2020, and February 28, 2021. Primary outcomes included development of critical …

[HTML][HTML] COVID-19 И САРКОИДОЗ: КОМОРБИДНОСТЬ, ПОСЛЕДСТВИЯ, ПРИЧИННО-СЛЕДСТВЕННЫЕ СВЯЗИ. ОБЗОР ЛИТЕРАТУРЫ

АА Визель, ИЮ Визель, ГР Шакирова… - Вестник современной …, 2022 - cyberleninka.ru
Введение. Саркоидоз и COVID-9 являются заболеваниями, в патогенезе которых
существенную роль играет реакция иммунной системы человека. Описания случаев …

Critical care of patients with cardiopulmonary complications of sarcoidosis

JK Lui, N Mesfin, D Tugal, ES Klings… - Journal of Intensive …, 2022 - journals.sagepub.com
Sarcoidosis is a systemic inflammatory disease defined by the presence of aberrant
granulomas affecting various organs. Due to its multisystem involvement, care of patients …

COVID‐19 pneumonia in a patient with sarcoidosis: A case report

H Ramdani, K Benelhosni… - Clinical Case …, 2021 - Wiley Online Library
COVID‐19 pneumonia in a patient with sarcoidosis: A case report - Ramdani - 2021 - Clinical
Case Reports - Wiley Online Library Skip to Article Content Skip to Article Information Wiley …

Pulmonary sarcoidosis

S Dhooria, A Chopra, M Munavvar - Frontiers in Medicine, 2023 - frontiersin.org
Sarcoidosis is a multisystem granulomatous disorder of unknown cause (1). It is the most
common diffuse parenchymal lung disease encountered at most interstitial lung disease …

Sarcoidosis in a time of pandemic

P Govender, YC Cozier - European Respiratory Journal, 2020 - Eur Respiratory Soc
We are living in a historic event: a novel virus, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China at the end of 2019 and began its …

Sarcoidosis during COVID-19 new pandemic infection

AA Vizel, IY Vizel, GR Shakirova - Medical alphabet, 2020 - med-alphabet.com
A literature review of the combination of sarcoidosis and the novel COVID-19 infection is
presented. In mild forms of sarcoidosis, without a decrease in lung function and without …

[PDF][PDF] Sarcoidosis and COVID-19: At the Cross-Road Between Im-Munopathology and Clinical Manifestation. Biomedicines 2022, 10, 2525

C Tana, F Cinetto, C Mantini, N Bernardinello, M Tana… - 2022 - researchgate.net
Coronavirus disease 2019 (COVID-19) has been associated with dysregulation of the
immune system featuring inappropriate immune responses, exacerbation of inflammatory …

[PDF][PDF] Solicitous use of injection remdesivir, tablet baricitinib, and plasma therapy for severe COVID-19 patient associated with Stage 4 sarcoidosis and type 2 …

M Bajaj, AK Saxena, S Choudhary… - Indian Journal of Case …, 2021 - mansapublishers.com
ABSTRACT COVID-19 infection caused by single-stranded RNA virus was declared as a
global pandemic by the WHO. Various concomitant diseases including diabetes …

Treatment of sarcoidosis in US rheumatology practices: comment on the article by Hamman et al.

AMF Yee - Arthritis Care & Research, 2022 - search.ebscohost.com
In what is, in effect, an important needs assessment, Hamman et al, in an article recently
published in I Arthritis Care & Research i ([1]), deftly invite an overdue dialog on the …